Danimer Scientific

Danimer Scientific Announces First Quarter 2024 Results

Retrieved on: 
Martedì, Maggio 7, 2024

Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its first quarter ended March 31, 2024.

Key Points: 
  • Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its first quarter ended March 31, 2024.
  • Adjusted EBITDA was $(8.7) million in the first quarter of 2024 which improved as compared to $(8.9) million in the first quarter of 2023.
  • The Company will host a webcast and conference call today, Tuesday, May 7, 2024, at 4:30 p.m. Eastern time to review first quarter 2024 results, discuss recent events and conduct a question-and-answer session.
  • Upon dialing in, please request to join the Danimer Scientific First Quarter 2024 Earnings Conference Call.

Danimer Scientific Reveals New Branding and New Applications Based on PHA During NPE 2024

Retrieved on: 
Lunedì, Maggio 6, 2024

Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next-generation bioplastics company focused on the development and production of PHA biopolymers, is unveiling new commercial applications and branding during NPE 2024, North America’s largest plastics tradeshow, taking place this week in Orlando, FL.

Key Points: 
  • Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next-generation bioplastics company focused on the development and production of PHA biopolymers, is unveiling new commercial applications and branding during NPE 2024, North America’s largest plastics tradeshow, taking place this week in Orlando, FL.
  • With full PHA production capability in place, Danimer is poised for significant growth with commercial partners for several applications, including cutlery, flexible food packaging and paper packaging barrier coatings.
  • Bolthouse Farms launched a new carrot package with Danimer PHA at Meijer stores in early 2024.
  • Stop by our NPE booth at S27027 to see our partner wall and all of the new commercial applications in person.

Danimer Scientific Announces Proposed Pro-Rata Distribution of Warrants to Purchase Common Stock

Retrieved on: 
Giovedì, Maggio 2, 2024

Danimer Scientific, Inc. (NYSE: DNMR) (“Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced a proposed pro-rata dividend distribution of warrants (“Dividend Warrants”) to holders of the Company’s Class A Common Stock, par value $0.0001 per share (“Common Stock”) as of May 13, 2024 (“Record Date”).

Key Points: 
  • Danimer Scientific, Inc. (NYSE: DNMR) (“Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced a proposed pro-rata dividend distribution of warrants (“Dividend Warrants”) to holders of the Company’s Class A Common Stock, par value $0.0001 per share (“Common Stock”) as of May 13, 2024 (“Record Date”).
  • After the Distribution Date, the Dividend Warrants are expected to list and trade on the OTCQX market, separate from Danimer Scientific’s Common Stock, which will continue to trade on the New York Stock Exchange.
  • As an example, a stockholder who owns 3,000 shares of Common Stock would receive 1,000 Dividend Warrants, and a stockholder who owns 1,000 shares of Common Stock would receive 333 Dividend Warrants.
  • The Company expects to file with the SEC a registration statement to register the shares of Common Stock underlying the Dividend Warrants.

Danimer Scientific Announces Release Date for First Quarter 2024 Results

Retrieved on: 
Mercoledì, Maggio 1, 2024

Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its first quarter 2024 financial results after the market closes on Tuesday May 7, 2024.

Key Points: 
  • Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its first quarter 2024 financial results after the market closes on Tuesday May 7, 2024.
  • A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company’s first quarter results, discuss recent events and conduct a question and-answer session.
  • The live webcast of the conference will be accessible on the Investor Relations section of the Company’s website at https://ir.danimerscientific.com .
  • Upon dialing in, please request to join the Danimer Scientific First Quarter 2024 Earnings Conference Call.

Danimer Scientific Announces $20 Million Asset-Based Revolving Credit Facility

Retrieved on: 
Lunedì, Aprile 22, 2024

Danimer Scientific, Inc. (NYSE: DNMR) (the “Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today, that on April 19, 2024, it entered into an asset-based revolving credit and security agreement with Mountain Ridge Capital secured primarily by the Company’s accounts receivable and inventory.

Key Points: 
  • Danimer Scientific, Inc. (NYSE: DNMR) (the “Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today, that on April 19, 2024, it entered into an asset-based revolving credit and security agreement with Mountain Ridge Capital secured primarily by the Company’s accounts receivable and inventory.
  • The credit and security agreement provides for borrowings under a revolving commitment of $20 million with availability determined by a borrowing base formula as provided in the agreement.
  • The agreement, among other things, also allows for increases in the commitment up to an additional $5 million and matures on or about April 19, 2027 (earlier maturity is subject to occurrence of certain events).
  • Revolving loans are expected to be used, among other things, for general corporate purposes and working capital needs as permitted by the credit and security agreement.

Danimer Scientific Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Giovedì, Marzo 28, 2024

Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its fourth quarter and full year, ended December 31, 2023.

Key Points: 
  • Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its fourth quarter and full year, ended December 31, 2023.
  • Our recently completed equity offering transaction enhances our operational liquidity runway and should enable us to support this expected growth.”
    Fourth Quarter 2023 Financial Highlights:
    Revenues were $10.9 million in the fourth quarter of 2023 compared to revenue of $15.3 million in the fourth quarter of 2022.
  • Adjusted EBITDA was $(10.7) million in the fourth quarter of 2023 compared to $(8.6) million in the fourth quarter of 2022.
  • Upon dialing in, please request to join the Danimer Scientific Fourth Quarter 2023 Earnings Conference Call.

Danimer Scientific Announces Closing of $15 Million Registered Direct Offering

Retrieved on: 
Lunedì, Marzo 25, 2024

Roth Capital Partners acted as the exclusive placement agent for the offering.

Key Points: 
  • Roth Capital Partners acted as the exclusive placement agent for the offering.
  • The gross proceeds to the Company from the offering were approximately $15 million before deducting placement agent fees and other offering expenses payable by the Company.
  • The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.
  • A final prospectus supplement and accompanying prospectus relating to the registered direct offering were filed with the SEC.

Danimer Scientific Announces Preliminary Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Mercoledì, Marzo 20, 2024

Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced preliminary results for its fourth quarter and full year, ended December 31, 2023.

Key Points: 
  • Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced preliminary results for its fourth quarter and full year, ended December 31, 2023.
  • Preliminary Fourth Quarter 2023 Results:
    Preliminary total revenue was $10.9 million for the fourth quarter of 2023 compared to revenue of $15.3 million for the fourth quarter of 2022.
  • Preliminary Adjusted EBITDA was $(10.7) million for the fourth quarter of 2023 compared to $(8.6) million for the fourth quarter of 2022.
  • Upon dialing in, please request to join the Danimer Scientific Fourth Quarter 2023 Earnings Conference Call.

Danimer Scientific Announces $15 Million Registered Direct Offering

Retrieved on: 
Giovedì, Marzo 21, 2024

The closing of the offering is expected to occur on or about March 25, 2024, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about March 25, 2024, subject to the satisfaction of customary closing conditions.
  • Roth Capital Partners is acting as the exclusive placement agent for the offering.
  • The gross proceeds to the Company from the offering are expected to be approximately $15 million before deducting placement agent fees and other offering expenses payable by the Company.
  • A final prospectus supplement and accompanying prospectus relating to the registered direct offering will be filed with the SEC.

Global Bioplastics and Advanced Plastics Recycling Report 2024-2034: Market Challenges and Opportunities in Scaling Up Environment-friendly Solutions Aligned with Principles of Circular Economy - ResearchAndMarkets.com

Retrieved on: 
Lunedì, Marzo 4, 2024

The "Global Market for Bioplastics and Advanced (Chemical) Plastics Recycling 2024-2034" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Market for Bioplastics and Advanced (Chemical) Plastics Recycling 2024-2034" report has been added to ResearchAndMarkets.com's offering.
  • Innovation in bioplastics and plastics recycling is spurring a renaissance in the petrochemical industry, with the latest technologies reinventing plastic and making waste plastic a new resource.
  • The Global Market for Bioplastics and Advanced (Chemical) Plastics Recycling 2024-2034 provides a comprehensive analysis of the global bio-based feedstocks, bio-based plastics, and advanced chemical recycling markets.
  • An extensive section is dedicated to the global bio-based and biodegradable plastics market, segmented by types including PLA, PHA, PBS, bio-PET etc.